Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

@article{Elbeik2000QuantitativeAC,
  title={Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.},
  author={Tarek A Elbeik and Edwin D Charlebois and Patricia S Nassos and James R. Kahn and Frederick M. Hecht and D. M. Yajko and Valerie P Ng and Keith S. Hadley},
  journal={Journal of clinical microbiology},
  year={2000},
  volume={38 3},
  pages={1113-20}
}
Quantification of human immunodeficiency virus type 1 (HIV-1) RNA as a measure of viral load has greatly improved the monitoring of therapies for infected individuals. With the significant reductions in viral load now observed in individuals treated with highly active anti-retroviral therapy (HAART), viral load assays have been adapted to achieve greater sensitivity. Two commercially available ultrasensitive assays, the Bayer Quantiplex HIV-1 bDNA version 3.0 (bDNA 3.0) assay and the Roche… CONTINUE READING